Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas
Clinical trial NCT00295178 · COMPLETED
Trial details
- NCT number
- NCT00295178
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-20
- Primary completion
- 2006-08-09
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.